Our Portfolio Planning & Risk Management Tutorials Part 1 & 2 are now available at HS Talks <read more here>                     We invite you to meet us at the BIO Int’l Convention at San Diego, June 19-22 <contact info>                     Our Portfolio Planning & Risk Management Tutorials Part 1 & 2 are now available at HS Talks <read more here>                     We invite you to meet us at the BIO Int’l Convention at San Diego, June 19-22 <contact info>                     Our Portfolio Planning & Risk Management Tutorials Part 1 & 2 are now available at HS Talks <read more here>                     We invite you to meet us at the BIO Int’l Convention at San Diego, June 19-22 <contact info>                     Our Portfolio Planning & Risk Management Tutorials Part 1 & 2 are now available at HS Talks <read more here>                     We invite you to meet us at the BIO Int’l Convention at San Diego, June 19-22 <contact info>                    
 
Home      About      Team      Clients      Publications      Downloads      News      Contact            

Testimonials
  Both, breadth and depth of Bioscience Valuation's economic assessments as well as the company's excellent knowledge of healthcare markets are invaluable assets for me in order to reach my goals.

Rick Jackson, Chairman and CEO
Jackson Healthcare

 

Core Services
  Financial Valuation
  Commercial Assessment &
Pharmacoeconomics

  R&D Risk Analysis &
Productivity Increase

  Portfolio Management
  Investment Decisions
  Partnering / Licensing
  Corporate Finance / M&A

Special Expertise
  Economic Modeling
of Healthcare Systems

  Assessing the Economics
of Personalized Medicine

Comprehensive Support
  Corporate Partnership Program

Products
  Market Model
  R&D Risk Model
  Valuation Model

Bioscience Valuation's Publications


GREUEL, J. (2017)Portfolio Planning and Risk Management in the Pharmaceutical Industry 1. In THE BIOMEDICAL & LIFE SCIENCES COLLECTION. London: Henry Stewart Talks Ltd.
(Online at https://hstalks.com/bs/3471/).

GREUEL, J. (2017)Portfolio Planning and Risk Management in the Pharmaceutical Industry 2. In THE BIOMEDICAL & LIFE SCIENCES COLLECTION. London: Henry Stewart Talks Ltd.
(Online at https://hstalks.com/bs/3472/).

GREUEL, J. (2016) The Role of Modern Portfolio Management in Pharma Innovation. In SCHUHMACHER, A., HINDER, M. & GASSMANN, O. (eds.). Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA. p.449-458.

NICKISCH, K. & BODE-GREUEL, K. (2016) Biosimilars Or Biobetters: Make Your Decisions Wisely. Research & analysis Journals. 2 (8). p.530-535.

BODE-GREUEL, K. & NICKISCH, K. (2014) Deciding between biobetter versus biosimilar development options based on net present value calculations. Journal of Commercial Biotechnology. 20 (2). p.21-31.

NICKISCH, K. & BODE-GREUEL, K. (2013) NPV modelling for the selection of value-creating biosimilar development candidates. Journal of Commercial Biotechnology. 19 (1). p.24-32.

BODE-GREUEL, K. (2011) Management strategischer und operativer Risiken in der Arzneimittelentwicklung. Pharmazeutische Medizin. 13 (3). p.178-183.

BODE-GREUEL, K. & WAGNER, C. (2011) Consultants' Perspectives: Bioscience Valuation.
Focus Oncology. 3. p.13-17.

BODE-GREUEL, K. (2010) Optimierung der Risikostruktur klinischer Engtwicklungsprojekte. DGPharMed News. 12 (3). p.111-115.

BODE-GREUEL, K. & GREUEL, J. (2010) Bewertung von Biotech-Unternehmen. In DRUKARCZYK, J. & ERNST, D. (eds.). Branchenorientierte Unternehmensbewertung. 3rd Ed., Munich: Verlag Franz Vahlen. p.293-308.

BODE-GREUEL, K., GREUEL, J. and NICKISCH, K. (2009) How can pharmaceutical and biotech companies maintain a high profitability? Journal of Commercial Biotechnology. 15 (4). p.309-323.

BODE-GREUEL, K. & NICKISCH, K. (2008) Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development - Commonalities and differences in portfolio management practice. Journal of Commercial Biotechnology. 14 (4). p.307-325.

GREUEL, J. (2008) Pharma and Biotech: Is it possible to continue growing? Pharma Focus Asia. 6. p.6-9.

GREUEL, J. (2005) Assessing the economics of biogenerics. Journal of Generic Medicines. 2 (2). p.153-160.

BODE-GREUEL, K. & GREUEL, J. (2005) Determining the value of drug development candidates and technology platforms. Journal of Commercial Biotechnology. 11 (2). p.155-170.

GREUEL, J. (2002) The R&D value conundrum. Current Drug Discovery. July. p.37-42.

LOCH, C. & BODE-GREUEL, K. (2001) Evaluating growth options as sources of value for pharmaceutical research projects. R&D Management . 31 (2). p.231-248.

BODE-GREUEL, K. (2000) Real Options Evaluation in Pharmaceutical R&D: A New Approach to Financial Project Evaluation. SCRIP Reports. BS1038, 17th February. London: PJB Publications Ltd.

BODE-GREUEL, K. (1998) Making wise decisions in pharmaceutical investment. Scrip Magazine. June. p.27-28.

BODE-GREUEL, K. (1997) Financial Project Evaluation and Risk Analysis in Pharmaceutial Development. SCRIP Reports. BS890, 27th November. London: PJB Publications Ltd.

Scientific Publications - Bioscience Valuation


GREUEL, J., LUHMANN, H. and SINGER, W. (1988) Pharmacological induction of use-dependent receptive field modifications in the visual cortex. Science. 7th October. 242 (4875). p.74-7.

KLISCH, J., BODE-GREUEL, K., HORVÁTH, E., KLISCH, C. and ELS, T. (2003) Additive neuroprotective effect of Ketanserin and Ipsapirone on the hippocampal damage after transient forebrain ischemia in the Mongolian gerbil. Neurosci Lett. 15th May. 342 (1-2). p.25-28.

DE VRY, J., SCHOHE-LOOP, R., HEINE, H., GREUEL, J., MAULER, F., SCHMIDT, B. and GLASER, T. (1998) Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist. Journal of Pharmacology and Experimental Therapeutics. 284 (3). p.1082-94.

SOMMERMEYER, H., SCHREIBER, R., GREUEL, J., DE VRY, J. and GLASER, T. (1993) Anxiolytic effects of the 5-HT1A receptor agonist ipsapirone in the rat: neurobiological correlates. Eur J. Pharmacol. 10th August. 240 (1). p.29-37.

SIRETEANU, R., SINGER, W., FRONIUS, M., GREUEL, J., BEST, J., FIORENTINI, A., BISTI, S., SCHIAVI, C. and CAMPOS, E. (1993) Eye alignment and cortical binocularity in strabismic kittens: a comparison between tenotomy and recession. Vis Neurosci. May-June. 0 (3). p.541-9.

KLISCH, J. & BODE-GREUEL, K. (1992) Ketanserin reduces neuronal calcium accumulation and cell death in the hippocampus of the Mongolian gerbil after transient forebrain ischemia. Brain Res. 24th April. 578 (1-2). p.1-7.

GREUEL, J., GLASER, T. (1992) The putative 5-HT1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitro. Eur J Pharmacol. 11th February. 211(2). p.211-9.

BODE-GREUEL, K. & SINGER, W. (1991) Development changes of calcium currents in the visual cortex of the cat. Exp Brain Res. 84 (2). p.311-8.

BODE-GREUEL, K., KLISCH, J., HORVÁTH, E., GLASER, T. and TRABER, J. (1990) Effects of 5-hydroxytryptamine1A-receptor agonists on hippocampal damage after transient forebrain ischemia in the Mongolian gerbil. Stroke. 21st December (12 Suppl). IV. p.164-6.

LUHMANN, H., GREUEL, J., SINGER, W. (1990) Horizontal Interactions in Cat Striate Cortex: II. A Current Source-Density Analysis. Eur J. Neurosci. 2 (4). p.358-368.

LUHMANN, H., GREUEL, J. and SINGER, W. (1990) Horizontal Interactions in Cat Striate Cortex: III. Ectopic Receptive Fields and Transient Exuberance of Tangential Interactions. Eur J. Neurosci. 2 (4). p.369-377.

BODE-GREUEL, K., SINGER, W. (1989) The development of N-methyl-D-aspartate receptors in cat visual cortex. Brain Res Dev Brain Res. 1st April. 46 (2). p.197-204.

BODE-GREUEL, K., SINGER, W. (1988) Developmental changes of the distribution of binding sites for organic Ca2+-channel blockers in cat visual cortex. Exp Brain Res. 70 (2). p.266-75.

GREUEL, J., LUHMANN, H. and SINGER, W. (1987) Evidence for a threshold in experience-dependent long-term changes of kitten visual cortex. Brain Res. July. 431 (1). p.141-9.

ALTMANN, L., LUHMANN,H., GREUEL, J., SINGER, W. (1987) Functional and neuronal binocularity in kittens raised with rapidly alternating monocular occlusion. J. Neurophysiol. November. 58 (5). p.965-80.

BODE-GREUEL, K., SINGER, W. and ALDENHOFF, J. (1987) A current source density analysis of field potentials evoked in slices of visual cortex. Exp Brain Res. 69 (1). p.213-9.